Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CMPS
Stock Latest News
The Fly
Psychedelic: Atai Beckley granted U.S. patent for EMP-01
4d ago
ATAI
CMND
Premium
The Fly
Compass Pathways upgraded to Outperform at Oppenheimer on COMP360 potential
6d ago
CMPS
Premium
The Fly
Compass Pathways upgraded to Outperform from Perform at Oppenheimer
6d ago
CMPS
Premium
Ratings
Buy Rating for COMPASS Pathways: Accelerated Clinical Development and Strategic Position in Mental Health Sector
1M ago
CMPS
Premium
The Fly
Psychedelic: Compass Pathways, GH Research report Q3 earnings
1M ago
PBM
ATAI
Premium
Company Announcements
Compass Pathways Accelerates Launch Plans Amid Positive FDA Talks
1M ago
CMPS
Premium
Company Announcements
Compass Pathways Earnings Call Highlights Progress and Plans
1M ago
CMPS
Premium
Ratings
Accelerated Phase 3 Timeline and Strong Financials Boost COMPASS Pathways’ Prospects
1M ago
CMPS
Premium
Pre-Earnings
Is CMPS a Buy, Before Earnings?
1M ago
CMPS
Premium
The Fly
Psychedelic: Compass Pathways, NeuroKaire enter R&D collaboration
2M ago
ATAI
CMND
Premium
The Fly
Compass Pathways, NeuroKaire enter R&D collaboration
2M ago
CMPS
Premium
Company Announcements
Compass Pathways Appoints Dr. Jeffrey Jonas to Board
2M ago
8K
CMPS
Premium
Company Announcements
Compass Pathways’ Psilocybin Study: A Potential Game-Changer for Treatment-resistant Depression
2M ago
CMPS
Premium
Ratings
Buy Rating for COMPASS Pathways: Strong Position in Psychedelic Treatment and Clinical Excellence
2M ago
CMPS
Premium
The Fly
Psychedelic: Exclusive talk with ibogaine clinic Beond
3M ago
ATAI
CMND
Premium
Ratings
Positive Clinical Results and Strategic Advancements Drive Buy Rating for COMPASS Pathways
3M ago
CMPS
Premium
The Fly
Psychedelic: Bright Minds reports preclinical BMB-201 results
3M ago
CMPS
CYBN
Premium
The Fly
Compass Pathways’ COMP360 psilocybin shows positive efficacy, tolerance results
3M ago
CMPS
Premium
The Fly
Psychedelic: Exclusive talk with biopharma company Reunion Neuroscience
4M ago
ATAI
CMND
Premium
Company Announcements
Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Depression Treatment
4M ago
CMPS
Premium
Company Announcements
Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Treatment-resistant Depression
4M ago
CMPS
Premium
Ratings
Optimistic Buy Rating for COMPASS Pathways Amidst Promising Phase 3 Trials and Regulatory Support
4M ago
CMPS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
